LONDON (AP) — The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing ...

The task force determines which preventive services insurers must cover at no cost to patients.

The European Union's drugs regulator has recommended approval of Gilead Sciences' lenacapavir, a twice-yearly injection, for ...

The drug is administered subcutaneously twice a year, making it easier for high-risk patients to comply with prophylaxis.

In 2024, studies suggested that lenacapavir, already used to treat people with HIV, was nearly 100% effective in stopping ...

Health Secretary Robert F. Kennedy Jr. is planning to remove all the members of an advisory panel that determines what cancer ...

Medical professionals Timothy Holtz and Teri Mills worked with AIDS patients in the 1990s, when treatments were few. With ...

The Trump administration is considering a dramatic cutback and eventual phasing out of the President’s Emergency Plan for ...

CHENNAI: Gilead Sciences has achieved another milestone in its efforts to bring in a preventive drug to curb the still ...

A federal judge on Thursday extended a temporary legal block that prevents Idaho from verifying the immigration status of ...

According to the police complaint, the 16-year-old girl was raped four times at Sevalay, a shelter-home for HIV-infected ...

A June HIV outreach event in Kota Bharu provided HIV/STI screenings, counselling, health talks, and meals for 70 participants ...